PBAC Public Summary Documents - March 2007

Public summary documents relating to the March 2007 PBAC meeting

Page last updated: 13 July 2007
 

• Adefovir dipivoxil tablet 10 mg (Hepsera)
• Budesonide with eformoterol fumarate dihydrate 100/6 & 200/6 (Symbicort)
• Carmustine implant 7.7 mg (Gliadel)
• Cetuximab 2 mg/mL in 50 mL (Erbitux)
• Dasatinib tablets 70 mg, 50 mg, 20 mg (Sprycel), (ALL)
• Dasatinib tablets 70 mg, 50 mg, 20 mg (Sprycel), (CML)
• Escitalopram tablet 10 mg and 20 mg and 10 mg/mL oral solution (Lexapro)
• Etanercept injection set containing 4 vials pwd for inj 25 mg and 50 mg and 4 pre-filled syringes solvent 1 mL (Enbrel)
• Fluticasone propionate with salmeterol xinafoate oral inhalation 250 mcg-25 mcg (base) per dose, (Seretide MDI 250/25) & powder for oral inhalation in breath actuated device 500 mcg-50 mcg (base) per dose (Seretide Accuhaler 500/50)
• Ibandronic acid tablets 150 mg (Bonviva)
• Infliximab powder for I.V. infusion 100 mg (Remicade)
• Insulin glulisine (human analogue) 100 unit per mL, 3 mL, 5 (Apidra)
• Interferon beta-1b injection set of 1 vial pwd for inj 8,000,000 i.u. (250 mcg) and solvent (Betaferon)
• Lanthanum carbonate chewable tablets 500 mg, 750 mg and 1000 mg (Fosrenol)
• Leflunomide tablet 10 mg and 20 mg (Arabloc/Arava)
• Letrozole tablet 2.5 mg (Femara)
• Levonorgestrel intrauterine drug delivery system 52 mg(20 mcg/24 hrs) (Mirena)
• Macrogol 3350 sachets containing powder for solution 13.125 g with electrolytes (Movicol)
• Memantine hydrochloride tablets 10 mg and 10 mg/mL drops (Ebixa)
• Nicotinic acid tablets prolonged release 500 mg 750 mg and 1000 mg (Niaspan)
• Olmesartan medoxomil with hydrochlorothiazide tablets 20 mg-12.5 mg, 40 mg-12.5 mg, 40 mg-25 mg (Olmetec Plus)
• Ramipril with felodipine tablets 2.5mg-2.5mg and 5 mg-5 mg (Triasyn)
• Ranibizumab 1.8 mg/0.3 mL or 3.0 mg/0.3 mL solution for intravitreal injection (Lucentis)
• Risedronate sodium 35 mg tablets x 4, 5 mg x 28 and Risedronate sodium 30 mg with calcium carbonate 1.25 g. (Actonel Actonel Combi)
• Rituximab solution for I.V. infusion 500 mg in 50 mL vials (Mabthera)
• Thyrotropin alfa-rch kit containing 2 vials of powder for I.M. injection 1.1 mg (Thyrogen)
• Sunitinib malate capsules 12.5 mg 25 mg and 50 mg (Sutent)
• Sunitinib malate capsules 12.5 mg 25 mg and 50 mg (Sutent)
• Tipranavir 250 mg soft capsules (Aptivus)
• Topiramate tablets 25 mg and 50 mg (Topamax)
• Travoprost with timolol maleate, eye drops, 40 micrograms-5 mg (base) per mL (0.004%-0.5%), 2.5 mL